Research ExplorerJournalsCANCER TREAT REV Publications

CANCER TREAT REV - Cancer Treatment Reviews

1 - 14 out of 14Page size: 50

Publications

  1. 2023

  2. Epidemiology, clinical outcomes, and unmet needs of patients with human epidermal growth factor receptor 2-positive breast cancer and brain metastases: A systematic literature review

    Müller, V., Bartsch, R., Lin, N. U., Montemurro, F., Pegram, M. D. & Tolaney, S. M., 04.2023, In: CANCER TREAT REV. 115, p. 102527

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  3. 2022

  4. Interplay between coagulation and inflammation in cancer: Limitations and therapeutic opportunities

    Bauer, A. T., Gorzelanny, C., Gebhardt, C., Pantel, K. & Schneider, S. W., 01.2022, In: CANCER TREAT REV. 102, 102322.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  5. 2021

  6. Differences in oncological and toxicity outcomes between programmed cell death-1 and programmed cell death ligand-1 inhibitors in metastatic renal cell carcinoma: A systematic review and meta-analysis

    Mori, K., Pradere, B., Quhal, F., Katayama, S., Mostafaei, H., Laukhtina, E., Schuettfort, V. M., D'Andrea, D., Egawa, S., Bensalah, K., Schmidinger, M., Powles, T. & Shariat, S. F., 09.2021, In: CANCER TREAT REV. 99, 102242.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  7. 2019

  8. Hereditary prostate cancer - Primetime for genetic testing?

    EAU-YAU Prostate Cancer Working Group, 12.2019, In: CANCER TREAT REV. 81, p. 101927

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  9. 2018

  10. Palliative treatment of germ cell cancer

    Oing, C., Giannatempo, P., Honecker, F., Oechsle, K., Bokemeyer, C. & Beyer, J., 12.2018, In: CANCER TREAT REV. 71, p. 102-107 6 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  11. 2017

  12. Effects and moderators of exercise on quality of life and physical function in patients with cancer: An individual patient data meta-analysis of 34 RCTs

    Buffart, L. M., Kalter, J., Sweegers, M. G., Courneya, K. S., Newton, R. U., Aaronson, N. K., Jacobsen, P. B., May, A. M., Galvão, D. A., Chinapaw, M. J., Steindorf, K., Irwin, M. L., Stuiver, M. M., Hayes, S., Griffith, K. A., Lucia, A., Mesters, I., van Weert, E., Knoop, H., Goedendorp, M. M., Mutrie, N., Daley, A. J., McConnachie, A., Bohus, M., Thorsen, L., Schulz, K-H., Short, C. E., James, E. L., Plotnikoff, R. C., Arbane, G., Schmidt, M. E., Potthoff, K., van Beurden, M., Oldenburg, H. S., Sonke, G. S., van Harten, W. H., Garrod, R., Schmitz, K. H., Winters-Stone, K. M., Velthuis, M. J., Taaffe, D. R., van Mechelen, W., Kersten, M-J., Nollet, F., Wenzel, J., Wiskemann, J., Verdonck-de Leeuw, I. M. & Brug, J., 01.2017, In: CANCER TREAT REV. 52, p. 91-104 14 p.

    Research output: SCORING: Contribution to journal › SCORING: Review article › Research

  13. 2015

  14. The current role of systemic chemotherapy in the primary treatment of head and neck cancer

    Busch, C-J., Tribius, S., Schafhausen, P. & Knecht, R., 01.03.2015, In: CANCER TREAT REV. 41, 3, p. 217-21 5 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  15. 2014

  16. Melanotic and non-melanotic malignancies of the face and external ear - A review of current treatment concepts and future options

    Kolk, A., Wolff, K-D., Smeets, R., Kesting, M., Hein, R. & Eckert, A. W., 01.08.2014, In: CANCER TREAT REV. 40, 7, p. 819-37 19 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  17. Recent developments and current concepts in medulloblastoma

    Gerber, N. U., Mynarek, M., von Hoff, K., Friedrich, C., Resch, A. & Rutkowski, S., 01.04.2014, In: CANCER TREAT REV. 40, 3, p. 356-365 10 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  18. Immunological challenges for peptide-based immunotherapy in glioblastoma

    Mohme, M., Neidert, M. C., Regli, L., Weller, M. & Martin, R., 03.2014, In: CANCER TREAT REV. 40, 2, p. 248-58 11 p.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  19. 2011

  20. Intensity-modulated radiotherapy versus conventional and 3D conformal radiotherapy in patients with head and neck cancer: is there a worthwhile quality of life gain?

    Tribius, S. & Bergelt, C., 2011, In: CANCER TREAT REV. 37, 7, p. 511-519 7.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  21. 2010

  22. Development and approval of the trifunctional antibody catumaxomab (anti-EpCAM x anti-CD3) as a targeted cancer immunotherapy.

    Seimetz, D., Lindhofer, H. & Bokemeyer, C., 2010, In: CANCER TREAT REV. 36, 6, p. 458-467 6.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  23. Gene expression profiling for diagnosis and therapy in acute leukaemia and other haematologic malignancies.

    Bacher, U., Kohlmann, A. & Haferlach, T., 2010, In: CANCER TREAT REV. 36, 8, p. 637-646 8.

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review

  24. 1989

  25. Lymphokine (IL-2 and TNF-alpha) mediated cytolytic activity against glioma cells in vitro.

    Herrmann, H. D., Köppen, J., Kühl, N., Raschdorf, C. & Westphal, M., 1989, In: CANCER TREAT REV. 16, p. 21-27

    Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review